Clinical Trial Update: A Pilot Study of VEGF Inhibition in Patients With Lymphedema Following Breast Cancer Treatment [Phase 1]

View source ↗

Summary

A Phase 1 pilot study evaluated inhibition of vascular endothelial growth factor (VEGF) as a potential treatment for lymphedema after breast cancer treatment. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lymphedema

Drugs mentioned

• VEGF inhibitor (unspecified)

Snippet

Sponsor: Indiana University School of Medicine | Conditions: Breast Cancer, Lymphedema | Phase 1 | Status: COMPLETED